Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Huitongda Network Co., Ltd.’s US$284 Million Hong Kong Initial Public Offering and Listing
Clifford Chance has advised Huitongda Network Co., Ltd. on the deal while Cooley advised the joint sponsors and underwriters. Founded in late 2010, Nanjing-based Huitongda is...
Asymchem’s $917 Million Hong Kong Listing
Latham & Watkins LLP advised the underwriters in the transaction while Cooley and JunHe represented Asymchem Laboratories. Asymchem Laboratories (Tianjin) Co., Ltd (Asymchem), a leading drug...